| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NHS | Floating Rate Senior Note, Series A Note, Due Sep. 18, 2023 | Other | -$255 T | -16 M | -66.67% | $15,992,744.26 | 7.98 M | Aug 4, 2020 | See Footnotes | F1, F3, F4, F5 |
| transaction | NHS | Floating Rate Senior Note, Series A Note, Due Sep. 18, 2023 | Other | -$311 T | -17.6 M | -66.67% | $17,647,166.12 | 8.81 M | Aug 4, 2020 | See Footnotes | F1, F3, F4, F5 |
| transaction | NHS | Floating Rate Senior Note, Series A Note, Due Sep. 18, 2023 | Other | -$698 T | -26.4 M | -66.67% | $26,448,050.45 | 13.2 M | Aug 4, 2020 | See Footnotes | F1, F3, F4, F5 |
| transaction | NHS | Series B Mandatory Redeemable Preferred Shares | Other | -$49.1 B | -1.4 K | -100% | $35,092,143.82 | 0 | Aug 4, 2020 | See Footnotes | F2, F3, F4, F5 |
| transaction | NHS | Series C Mandatory Redeemable Preferred Shares | Purchase | $62 M | +4.96 M | $12.50 | 4.96 M | Aug 4, 2020 | See Footnotes | F4, F5 | |
| transaction | NHS | Series C Mandatory Redeemable Preferred Shares | Purchase | $12 M | +960 K | $12.50 | 960 K | Aug 4, 2020 | See Footnotes | F4, F5 | |
| transaction | NHS | Series C Mandatory Redeemable Preferred Shares | Purchase | $21 M | +1.68 M | $12.50 | 1.68 M | Aug 4, 2020 | See Footnotes | F4, F5 |
| Id | Content |
|---|---|
| F1 | These Floating Rate Senior Notes, Series A Notes, due September 18, 2023 ("Notes") were redeemed, in part, by the Issuer pursuant to a partial prepayment of the principal plus accrued and unpaid interest. |
| F2 | These Series B Mandatory Redeemable Preferred Shares ("Series B MRPS") were redeemed, in whole, by the Issuer at a price equal to the liquidation preference of $25,000 per share plus accumulated and unpaid dividends. |
| F3 | This price reflects the aggregate amount received in exchange for the redemption. |
| F4 | These Notes, Series B MRPS and Series C MRPS are held directly by clients for whom the Reporting Person serves as investment manager. |
| F5 | The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
The initial Form 3 was filed on October 9, 2013 by Metropolitan Life Insurance Company. Subsequent to that filing, management of positions in the Issuer's securities was transferred to MetLife Investment Management, LLC, who assumed the Section 16 reporting obligations for such positions.